These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 1385514)
1. Suicide risk and serotonin. Nordström P; Asberg M Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 6():12-21. PubMed ID: 1385514 [TBL] [Abstract][Full Text] [Related]
2. Serotonergic mechanisms in brains of suicide victims. Owen F; Chambers DR; Cooper SJ; Crow TJ; Johnson JA; Lofthouse R; Poulter M Brain Res; 1986 Jan; 362(1):185-8. PubMed ID: 2417665 [TBL] [Abstract][Full Text] [Related]
3. Altered serotonin function in suicide. Evidence from platelet and neuroendocrine studies. Pandey GN Ann N Y Acad Sci; 1997 Dec; 836():182-200. PubMed ID: 9616799 [TBL] [Abstract][Full Text] [Related]
4. Lower 3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high affinity, non-transporter sites. Mann JJ; Henteleff RA; Lagattuta TF; Perper JA; Li S; Arango V J Neural Transm (Vienna); 1996; 103(11):1337-50. PubMed ID: 9013420 [TBL] [Abstract][Full Text] [Related]
5. Postmortem evidence for serotonin's role in suicide. Stanley M; Stanley B J Clin Psychiatry; 1990 Apr; 51 Suppl():22-8; discussion 29-30. PubMed ID: 1691168 [TBL] [Abstract][Full Text] [Related]
6. CSF 5-HIAA predicts suicide risk after attempted suicide. Nordström P; Samuelsson M; Asberg M; Träskman-Bendz L; Aberg-Wistedt A; Nordin C; Bertilsson L Suicide Life Threat Behav; 1994; 24(1):1-9. PubMed ID: 7515519 [TBL] [Abstract][Full Text] [Related]
7. Biochemical aspects of suicidal behavior. Traskman-Bendz L; Asberg M; Nordstrom P; Stanley M Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S35-44. PubMed ID: 2616793 [TBL] [Abstract][Full Text] [Related]
10. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Arango V; Underwood MD; Gubbi AV; Mann JJ Brain Res; 1995 Aug; 688(1-2):121-33. PubMed ID: 8542298 [TBL] [Abstract][Full Text] [Related]
11. 5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology. Goodwin FK; Post RM Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):393S-405S. PubMed ID: 6190490 [TBL] [Abstract][Full Text] [Related]
12. Prophylactic potential of selective reuptake inhibitors in suicidal patients. Banki CM Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():61-5. PubMed ID: 7542677 [TBL] [Abstract][Full Text] [Related]
13. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Asberg M; Träskman L; Thorén P Arch Gen Psychiatry; 1976 Oct; 33(10):1193-7. PubMed ID: 971028 [TBL] [Abstract][Full Text] [Related]
14. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Owens MJ; Nemeroff CB Clin Chem; 1994 Feb; 40(2):288-95. PubMed ID: 7508830 [TBL] [Abstract][Full Text] [Related]
15. Differential abnormalities in plasma 5-HIAA and platelet serotonin concentrations in violent suicide attempters: relationships with impulsivity and depression. Spreux-Varoquaux O; Alvarez JC; Berlin I; Batista G; Despierre PG; Gilton A; Cremniter D Life Sci; 2001 Jun; 69(6):647-57. PubMed ID: 11476186 [TBL] [Abstract][Full Text] [Related]
16. The serotonin hypothesis of (auto)aggression. Critical appraisal of the evidence. Van Praag HM; Plutchik R; Conte H Ann N Y Acad Sci; 1986; 487():150-67. PubMed ID: 2436530 [TBL] [Abstract][Full Text] [Related]